Stewart & Patten CO LLC Abb Vie Inc. Transaction History

Stewart & Patten CO LLC

$664 Million
Q1 2024

A detailed history of Stewart & Patten CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stewart & Patten CO LLC holds 1,780 shares of ABBV stock, worth $305,679. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,780

Previous 2,511 29.11%

Holding current value

$305,679

Previous $389,000 16.71%

% of portfolio

0.05%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $116,828 - $133,115	-731 Reduced 29.11%	1,780 $324,000
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $86,825 - $97,786	631 Added 33.56%	2,511 $389,000
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $13,516 - $16,819	-102 Reduced 5.15%	1,880 $253,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $14,171 - $16,320	-98 Reduced 4.71%	1,982 $315,000
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $13,831 - $16,587	-100 Reduced 4.59%	2,080 $336,000
Q3 2022 Oct 19, 2022	BUY	$134.21 - $153.93 $30,868 - $35,403	230 Added 11.79%	2,180 $293,000
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $45,001 - $57,211	-327 Reduced 14.36%	1,950 $299,000
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $137,655 - $170,791	-1,043 Reduced 31.42%	2,277 $369,000
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $3,222 - $4,077	-30 Reduced 0.9%	3,320 $449,000
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $129,276 - $146,747	-1,215 Reduced 26.62%	3,350 $362,000
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $26,302 - $29,302	-250 Reduced 5.19%	4,565 $515,000
Q1 2021 Apr 21, 2021	SELL	$102.3 - $112.62 $51,150 - $56,310	-500 Reduced 9.41%	4,815 $521,000
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $48,294 - $65,202	-600 Reduced 10.14%	5,315 $570,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $24,827 - $29,139	-289 Reduced 4.66%	5,915 $518,000
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $330,165 - $441,810	-4,500 Reduced 42.04%	6,204 $609,000
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $251,550 - $381,381	-3,900 Reduced 26.71%	10,704 $816,000
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $14,170 - $17,037	-225 Reduced 1.52%	14,604 $1.11 Million
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $4,730 - $6,046	-72 Reduced 0.48%	14,829 $1.08 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $29,158 - $34,318	-378 Reduced 2.47%	14,901 $1.2 Million
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $5,838 - $7,200	75 Added 0.49%	15,279 $1.41 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $32,452 - $36,076	-365 Reduced 2.34%	15,204 $1.44 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $7,631 - $9,029	-85 Reduced 0.54%	15,569 $1.44 Million
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $36,804 - $49,284	-400 Reduced 2.49%	15,654 $1.48 Million
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $44,780 - $49,105	500 Added 3.21%	16,054 $1.55 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $1.09 Million - $1.39 Million	15,554	15,554 $1.38 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart & Patten CO LLC with notifications on news.

Account

Stewart & Patten CO LLC Abb Vie Inc. Transaction History